Melehy Andrew, Amara Dominic, Gumate Shreya, Ebaid Samer, Kaldas Fady M, Farmer Douglas G, Bui Alex A T, Agopian Vatche G
Department of Surgery, Dumont-UCLA Transplant and Liver Cancer Centers, David Geffen School of Medicine, University of California, Los Angeles, California, USA.
Department of Radiological Sciences, Medical & Imaging Informatics Group, University of California, Los Angeles, California, USA.
Liver Transpl. 2025 Apr 2. doi: 10.1097/LVT.0000000000000616.
Liver transplant (LT) centers may have variations in their approach to high-acuity (MELD ≥35) candidates for listing and transplantation. We investigated center-specific differences in waitlist outcomes, probability of LT, and post-LT survival in MELD ≥35 patients. Adult candidates of LT (MELD ≥35) were identified from the Scientific Registry of Transplant Recipients between January 1, 2010, and April 1, 2022. Waitlist mortality was modeled with the center as a random effect. Centers were grouped based on the random effect coefficient, with the highest tertile representing the highest risk group (comprises centers with the highest risk of waitlist mortality attributable to the center). Cumulative incidence of death/delisting, probability of LT, and 1-year post-LT survival were compared, with patients stratified by a listing MELD ≥35 or increase to MELD ≥35 after listing. In patients who increased to MELD ≥35, the 1-year cumulative incidence of death/delisting was highest (50%) and the probability of transplant lowest (46%) in the high-risk group, compared to the low-risk group (37% and 55%, p <0.001 for both comparisons). For patients receiving an LT, post-transplant survival did not differ among the groups, though high-risk centers transplanted far less high-acuity patients. These variations may indicate that certain centers are associated with substantially decreased waitlist mortality for the highest acuity patients without corresponding decreases in post-transplant survival.
肝移植(LT)中心在对待高急症(终末期肝病模型评分[MELD]≥35)的等待名单登记及移植候选人时,其方法可能存在差异。我们调查了MELD≥35患者在等待名单结果、肝移植概率及肝移植后生存率方面的中心特异性差异。2010年1月1日至2022年4月1日期间,从器官移植受者科学登记处识别出成年肝移植候选人(MELD≥35)。将中心作为随机效应,对等待名单死亡率进行建模。根据随机效应系数对中心进行分组,最高三分位数代表最高风险组(包括因中心因素导致等待名单死亡率最高的中心)。比较死亡/退出等待名单的累积发生率、肝移植概率及肝移植后1年生存率,并根据登记时MELD≥35或登记后升至MELD≥35对患者进行分层。在升至MELD≥35的患者中,高风险组的1年死亡/退出等待名单累积发生率最高(50%),移植概率最低(46%),而低风险组分别为37%和55%(两项比较p均<0.001)。对于接受肝移植的患者,尽管高风险中心移植的高急症患者少得多,但各风险组移植后的生存率并无差异。这些差异可能表明,某些中心与最高急症患者等待名单死亡率大幅降低相关,而移植后生存率并未相应降低。